References
- Housman TS, Rohrback JM, Fleischer AB Jr, Feldman SR. Phototherapy utilization for psoriasis is declining in the United States. J Am Acad Dermatol. 2002;46:557–559.
- National Psoriasis Foundation. National Psoriasis Foundation targets high phototherapy co-payments. Available from www.psoriasis.org/page.aspx?pid=514. Accessed July 17 2011.
- Buggiani G, Troiano M, Rossi R, Lotti T. Photodynamic therapy: off-label and alternative use in dermatological practice. Photodiagnosis Photodyn Ther. 2008;5:134–138.
- Hu J, Balkrishnan R, Camacho F, Lang W, Pearce DJ, Fleischer AB Jr, et al. The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis. J Cutan Med Surg. 2004;8:411–414.
- Rajpara AN, O'Neill JL, Nolan BV, Yentzer BA, Feldman SR. Review of home phototherapy. Dermatol Online J. 2010;16:2.
- Yentzer BA, Feldman SR. Trends in home phototherapy adoption in the US: monetary disincentives are only the tip of the iceberg. J Dermatolog Treat. 2011;22:27–30.
- Staidle JP, Dabade TS, Feldman SR. A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opin Pharmacother. 2011;12:2041–2054.